NO_LONGER_AVAILABLENCT02968953
Treatment With UX007 for a Single Patient With GLUT1 Deficiency Syndrome
Studying Classic glucose transporter type 1 deficiency syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Jerry Vockley, MD, PhD
- Principal Investigator
- Gerard Vockley, MD, PhD, ODUniversity of Pittsburgh
- Intervention
- Triheptanoin(drug)
- Eligibility
- 3 years · FEMALE
Study locations (1)
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States
Collaborators
Ultragenyx Pharmaceutical Inc
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02968953 on ClinicalTrials.govOther trials for Classic glucose transporter type 1 deficiency syndrome
Additional recruiting or active studies for the same condition.
See all trials for Classic glucose transporter type 1 deficiency syndrome →